AR119765A1
(en )
2022-01-12
IMIDAZOLIL PYRIMIDINILAMINE COMPOUNDS AS CDK2 INHIBITORS
CY1123631T1
(en )
2022-03-24
SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS
MA43753A
(en )
2018-11-28
1-CYANO-PYRROLIDINE DERIVATIVES AS DBU INHIBITORS
AR120184A1
(en )
2022-02-02
BICYCLIC AMINES AS INHIBITORS OF CDK2
FR24C1009I1
(en )
2024-05-24
COMPOUNDS USED AS KINASE INHIBITORS
ES2974445T3
(en )
2024-06-27
Aminopyrimidine derivatives as CTPS1 inhibitors
AR126102A1
(en )
2023-09-13
TRICYCLIC HETEROCYCLES AS FGFR INHIBITORS
CR20140024A
(en )
2014-07-02
METALOENZYM INHIBITING COMPOUNDS
CR20140106A
(en )
2014-05-02
COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF THE QUINASE C-KIT
UY33925A
(en )
2012-09-28
TRICYCLIC QUINASE INHIBITORS
CR20150018A
(en )
2015-06-04
MACROCYCLIC INHIBITORS OF VIRUS FLAVIVIRIDAE
CR20120659A
(en )
2013-03-11
PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR CANCER TREATMENT
BR112012029405A2
(en )
2016-12-06
macrocyclic compounds as trk kinase inhibitors
CR20120641A
(en )
2013-03-11
MACROCYCLICAL COMPOUNDS AS QUINASA TRK INHIBITORS
DOP2014000033A
(en )
2014-06-01
AMINOQUINAZOLINS AS QUINASE INHIBITORS
BR112018003812A2
(en )
2018-09-25
heteroaryl compounds as irak inhibitors and their uses
UY34051A
(en )
2012-11-30
PIRROLOTRIAZINONA DERIVATIVES AS PI3K INHIBITORS
UY34648A
(en )
2013-09-02
AMIDAS AS PIM INHIBITORS
UY34502A
(en )
2013-05-31
ARILOS AND BICYCLIC INHIBITORS OF SODIUM CHANNELS
CU20110159A7
(en )
2012-02-15
FUSIONATED PYRIMIDINS
EA201692521A1
(en )
2017-05-31
PYRAZOL COMPOUNDS AND THEIR APPLICATION AS BLOCATORS OF T-TYPE CALCIUM CHANNELS
AR125273A1
(en )
2023-07-05
SPIROCYCLIC LACTAMS AS JAK2 INHIBITORS V617F
MA55478A
(en )
2022-02-09
BICYCLIC HPK1 INHIBITORS
MA41803A
(en )
2018-01-30
AMINO-INDAZOLES USED AS SODIUM CHANNEL INHIBITORS
MA52891A
(en )
2021-04-28
AZA-INDOLIC DERIVATIVES USED AS RHO-KINASE INHIBITORS